
Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQMHM1N3VvRnZfRG9rSjlGZkh5TnhXVldYS1g1TzRHYU5PTVJHYUllUEF3NkNBaEo0S3N2aWgyN1lYTl9HSEVvemtnNkp5X3pzbXZhU1pyRUN5VG8xRHJ2X2Q0Q2UwS1V5M3Y1LWk5X2JvSTdqNFRDTFpwelNDUy1sNzlTYW5nd3VmbW84Slg2bW1UMHNSblo3ZTM4ckxLZFlO?oc=5" target="_blank">Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
